EQSNews: HeartBeat.bio AG
/ Key words: Agreement
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
05.10.2022 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
HeartBeat.bio c... Lire le communiqué |